Cent Eur J Immunol. 2019;44(1):92-96. doi: 10.5114/ceji.2019.83615. Epub 2019 Apr 15.
Investigations of cellular immunity in juvenile idiopathic arthritis.
Central-European journal of immunology
Lucia Maria Sur, Genel Sur, Gabriel Samasca, Iulia Lupan
Affiliations
Affiliations
- Department of Paediatrics I, "Iuliu Ha?ieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
- Department of Paediatrics II, "Iuliu Ha?ieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
- Department of Immunology, "Iuliu Ha?ieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
- Department of Molecular Biology, "Babes-Bolyai" University, Cluj-Napoca, Romania.
PMID: 31114442
PMCID: PMC6526591 DOI: 10.5114/ceji.2019.83615
Abstract
The following was emphasised in an informative, educational issued on the American College of Rheumatology website in April 2017: "About one child in every 1000 develops some type of chronic arthritis. These disorders can affect children at any age, although rarely in the first six months of life. It is estimated that around 300,000 children in the United States have been diagnosed with the condition". Therefore, knowledge of immunological investigations in patients with juvenile idiopathic arthritis is important for finding new treatment pathways. Our aim was to assess the immunological investigations and immune system implications in juvenile idiopathic arthritis. We will discuss: a) the specifically targeted proteins - the citrullinated peptide antibodies; b) non-specifically targeted proteins - heat-shock proteins (anti-HSP60, -65, and -70 antibodies), CLEC16A, inflammasomes, and phagocyte-derived S100; c) interleukins - IL-1, IL-6, IL-10, IL-17, and IL-18; d) innate immunity - macrophage activation syndrome, natural killer cells, complement activity, and immune complexes; and e) therapeutic targets - monoclonal antibodies, JAK inhibitors, and intravenous immune globulin.
Keywords: immunological targets; immunopathology; juvenile idiopathic arthritis
Conflict of interest statement
The authors declare no conflict of interest.
References
- Autoimmunity. 2002 Sep;35(6):397-401 - PubMed
- J Autoimmun. 2006 Sep;27(2):81-8 - PubMed
- Scand J Immunol. 2007 Jan;65(1):76-83 - PubMed
- Clin Rev Allergy Immunol. 2007 Feb;32(1):47-56 - PubMed
- Immunology. 2007 Oct;122(2):291-301 - PubMed
- Autoimmun Rev. 2008 Feb;7(4):305-8 - PubMed
- J Immunoassay Immunochem. 2008;29(3):281-98 - PubMed
- Immunol Invest. 2008;37(8):849-57 - PubMed
- J Autoimmun. 2009 Nov-Dec;33(3-4):208-13 - PubMed
- Genes Immun. 2010 Sep;11(6):504-8 - PubMed
- Clin Immunol Immunopathol. 1991 Aug;60(2):232-43 - PubMed
- Autoimmun Rev. 2011 Jun;10(8):482-9 - PubMed
- Genes Immun. 2012 Jun;13(4):289-98 - PubMed
- Nat Rev Immunol. 2012 Jul 25;12(8):570-80 - PubMed
- Clin Immunol. 2013 Jun;147(3):229-41 - PubMed
- Hum Immunol. 2013 Aug;74(8):986-92 - PubMed
- Semin Immunol. 2014 Feb;26(1):97-104 - PubMed
- Semin Immunol. 2014 Feb;26(1):88-96 - PubMed
- Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):33-48 - PubMed
- Cytokine Growth Factor Rev. 2015 Feb;26(1):35-45 - PubMed
- Int Immunol. 2015 Jan;27(1):21-9 - PubMed
- Expert Rev Clin Immunol. 2014 Nov;10(11):1427-35 - PubMed
- Clin Rev Allergy Immunol. 2015 Oct;49(2):253-61 - PubMed
- J Immunol Res. 2015;2015:915276 - PubMed
- Expert Rev Clin Immunol. 2015 May;11(5):575-88 - PubMed
- Autoimmun Rev. 2015 Aug;14(8):651-8 - PubMed
- Autoimmun Rev. 2015 Sep;14(9):769-73 - PubMed
- Clin Immunol. 2015 Jul;159(1):72-83 - PubMed
- Semin Immunopathol. 2015 Jul;37(4):387-94 - PubMed
- Immunity. 2015 May 19;42(5):942-52 - PubMed
- J Autoimmun. 2015 Jul;61:1-8 - PubMed
- Semin Immunopathol. 2015 Jul;37(4):403-6 - PubMed
- Clin Immunol. 2015 Oct;160(2):277-81 - PubMed
- Clin Immunol. 2015 Dec;161(2):163-9 - PubMed
- Expert Rev Clin Immunol. 2015;11 Suppl 1:S5-14 - PubMed
- Eur J Immunol. 2016 Feb;46(2):269-80 - PubMed
- Immunotherapy. 2016;8(1):79-87 - PubMed
- Immunotherapy. 2016 Feb;8(2):127-33 - PubMed
- Cent Eur J Immunol. 2015;40(4):470-6 - PubMed
- Clin Immunol. 2016 Apr;165:21-8 - PubMed
- Bratisl Lek Listy. 2016;117(5):258-62 - PubMed
- Front Immunol. 2016 May 20;7:177 - PubMed
- Clin Immunol. 2016 Aug;169:8-13 - PubMed
- Clin Rev Allergy Immunol. 2018 Jun;54(3):375-385 - PubMed
- Front Immunol. 2016 Jun 13;7:203 - PubMed
- Eur J Immunol. 2016 Sep;46(9):2068-77 - PubMed
- Immunology. 2016 Oct;149(2):131-8 - PubMed
- J Autoimmun. 2017 Feb;77:55-66 - PubMed
- J Clin Rheumatol. 2016 Dec;22(8):446-448 - PubMed
- Ital J Pediatr. 2017 Jan 17;43(1):9 - PubMed
- Expert Opin Drug Saf. 2017 Apr;16(4):493-500 - PubMed
- Expert Opin Investig Drugs. 2017 Apr;26(4):381-387 - PubMed
- Vestn Oftalmol. 2017;133(1):27-31 - PubMed
- Arthritis Rheumatol. 2017 Jul;69(7):1480-1494 - PubMed
- F1000Res. 2017 Jun 22;6:971 - PubMed
- Harefuah. 2017 Jul;156(7):427-430 - PubMed
- J Clin Lab Immunol. 1988 Mar;25(3):115-8 - PubMed
- Clin Exp Immunol. 1995 Jun;100(3):514-8 - PubMed
- J Clin Immunol. 1995 Nov;15(6 Suppl):42S-51S - PubMed
- Semin Immunol. 1998 Feb;10(1):35-41 - PubMed
Publication Types